ArticleScientific reports2025
Identification of potential natural analgesic compounds through molecular docking-virtual screening, molecular dynamics simulation, MM/GBSA, DFT, and ADMET computations.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Theoretical visualization of covalent and non-covalent interactions: molecular diversity and substituent effects governing the reactivity of Bulbophyllum bibenzyl derivatives.Molecular diversity · 2026Article
- A Comprehensive Study Utilizing QSAR, Virtual Screening, Molecular Docking, Molecular Dynamics, and MM/GBSA Analyses Reveals Natural Diterpenoids as Promising Caspase-1 Inhibitors.Molecules (Basel, Switzerland) · 2026Article
- Neurovascular Involvement in Arterial Tortuosity Syndrome Associated with a HomozygousInternational journal of molecular sciences · 2026Article
- AI-driven quantum chemical exploration of multi-target synthetic opioid analogs for enhanced therapeutic profiles.Journal of computer-aided molecular design · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study aimed to identify bioactive compounds from twelve medicinal plants known for their analgesic and anti-inflammatory properties using in silico approaches. The phytochemical components were subjected to cross-docking analyses against receptors implicated in pain and inflammation pathways. Based on binding energies, interaction profiles, and key amino acid residues within the receptor active sites, three compounds-apigenin, kaempferol, and quercetin-demonstrated the highest affinity for the cyclooxygenase-2 (COX-2) receptor. Notably, these compounds share similar structural scaffolds and exhibit analogous interactions with critical receptor residues. Furthermore, pharmacokinetic and toxicity assessments of the selected compounds indicated favorable oral bioavailability and an overall acceptable safety profile. Density functional theory (DFT) calculations revealed that these compounds possess relatively high softness. Molecular dynamics simulations of apigenin, kaempferol, quercetin, and the reference drug diclofenac complexed with COX-2 were performed over 100 ns. Analyses of root mean square deviation (RMSD), radius of gyration (Rg), root mean square fluctuation (RMSF), and ligand-protein interactions confirmed the stability of these complexes. Finally, MM/GBSA calculations estimated the binding free energies, with diclofenac and apigenin exhibiting the most favorable values. This study highlights pharmacologically active compounds potentially contributing to the analgesic effects of these plants. It underscores the value of such computational investigations in accelerating the discovery of specific bioactive agents responsible for therapeutic effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.